avav588con,最近2019中文免费字幕在线观看,欧美一道本一区二区三区,九九热在线观看,经典好看免费AV

武漢艾美捷科技有限公司
免費(fèi)會員

艾美捷Thapsigargin技術(shù)信息&文獻(xiàn)參考

時(shí)間:2022-10-25閱讀:92
分享:

艾美捷Thapsigargin背景:

在細(xì)胞中,肌肉/內(nèi)質(zhì)鈣 ATP (SERCA)將游離鈣轉(zhuǎn)運(yùn)到肌質(zhì)和內(nèi)質(zhì)網(wǎng)中,降低細(xì)胞內(nèi)鈣水平以阻止通過這種陽離子的信號傳導(dǎo)。毒胡蘿卜素是 SERCAs 鈣轉(zhuǎn)運(yùn)的非競爭性細(xì)胞滲透性抑制劑(IC50值是細(xì)胞類型依賴性的,范圍在2-80nM)。1,2毒胡蘿卜素的抑制導(dǎo)致細(xì)胞內(nèi)鈣的增加,這與細(xì)胞活化,肥大細(xì)胞釋放組胺和增加某些類型的癌細(xì)胞的增殖有關(guān)。1,3,4在體內(nèi),毒胡蘿卜素和相關(guān)的倍半萜內(nèi)酯具有抗炎和抗癌作用。5,6(參考文末文獻(xiàn))

 

11.jpg

艾美捷Thapsigargin技術(shù)信息:

正式名稱:

(3S,3aS,4R,6R,7S,8R)-6-acetoxy-4-(butyryloxy)-3,3a-dihydroxy-3,6,9-trimethyl-8-(((Z)-2-methylbut-2-enoyl)oxy)-2-oxo-2,3,3a,4,5,6,6a,7,8,9b-decahydro-1H-cyclopenta[e]azulen-7-yl octanoate

CAS編號:67526-95-8

分子式:C34H50O12

公式重量:650.8

純度:≥97%

配方:結(jié)晶狀固體

溶解度:

DMF: 30 mg/ml

DMSO30毫克/毫升

乙醇:30毫克/毫升

乙醇:PBSpH7.2)(12)。0.3 mg/ml

運(yùn)輸和存儲信息:

儲存:-20°C

運(yùn)輸:美國大陸的室溫;其他地方可能有所不同

穩(wěn)定性:≥ 4

 

艾美捷Thapsigargin相關(guān)文獻(xiàn)參考:

1. Sabala, P., Czarny, M., Woronczak, J.P., et al. Thapsigargin: Potent inhibitor of Ca2+ transport ATP-ases of endoplasmic and sarcoplasmic reticulum. Acta Biochim. Pol. 40(3), 309-319 (1993).

2. Treiman, M., Caspersen, C., and Christensen, S.B. A tool coming of age: Thapsigargin as an inhibitor of sarco-endoplasmic reticulum Ca2+-ATPases. Trends Pharmacol. Sci. 19(4), 131-135 (1998).

3. Ali, H., Christensen, S.B., Foreman, J.C., et al. The ability of thapsigargin and thapsigargicin to activate cells involved in the inflammatory response. Br. J. Pharmacol. 85(3), 705-712 (1985).

4. Jackson, T.R., Patterson, S.I., Thastrup, O., et al. A novel tumour promoter, thapsigargin, transiently increases cytoplasmic free Ca2+ without generation of inositol phosphates in NG115-401L neuronal cells. Biochem. J. 253(1), 81-86 (1988).

5. Christensen, S.B., Skytte, D.M., Deanmeade, S.R., et al. A Trojan horse in drug development: Targeting of thapsigargins towards prostate cancer cells. Anticancer Agents Med. Chem. 9(3), 276-294 (2009).

6. Ghantous, A., Gali-Muhtasib, H., Saliba, N.A., et al. What made sesquiterpene lactones reach cancer clinical trials? Drug Discov. Today 15(15-16), 668-678 (2010).


會員登錄

×

請輸入賬號

請輸入密碼

=

請輸驗(yàn)證碼

收藏該商鋪

X
該信息已收藏!
標(biāo)簽:
保存成功

(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)

常用:

提示

X
您的留言已提交成功!我們將在第一時(shí)間回復(fù)您~
在線留言